Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-07

Clinical Trial Update: Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants [NA]

View source ↗

Summary

A completed clinical trial assessed whether transdermal alcohol monitoring can reduce drinking among individuals charged with drunk driving.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Drunk Driving | NA | Status: COMPLETED